Melatonin excretion in normal children and in tuberous sclerosis complex with sleep disorder responsive to melatonin

Journal of Child Neurology

Volumn 20, Issue 1, 2005, Pages 21-25

  Hancock, Eleanor ^a   O'Callaghan, Finbar ^a   English, Judie ^a   Osborne, John P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

6 HYDROXYMELATONIN O SULFATE; MELATONIN;

ADOLESCENT; ARTICLE; BIOLOGICAL RHYTHM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG URINE LEVEL; HORMONE METABOLISM; HUMAN; PRIORITY JOURNAL; SLEEP DISORDER; SLEEP PATTERN; SLEEP TIME; TUBEROUS SCLEROSIS; URINARY EXCRETION;

EID: 15444367431     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738050200010301     Document Type: Article

References (15)

1. Bojkowski C, Arendt J: Factors influencing urinary 6-sulphatoxymelatonin, a major melatonin metabolite, in normal human subjects. Clin Endocrinol 1990;33:435-444.
2. Monk TH, Ford A: "Cosinor": A cosine curve fitting program suitable for small computers. Int J Chronobiol 1983;6:192-224.
3. Quine L, Pahl J: Stress and Coping in Families Caring for a Child With Severe Mental Handicap. Final Report to the Department of Health. Canterbury, UK, Institute of Social and Applied Psychology, University of Kent at Canterbury, 1989.
4. Hunt A, Stores G: Sleep disorder and epilepsy in children with tuberous sclerosis; a questionnaire-based study. Dev Med Child Neurol 1994;36:108-115.
5. O'Callaghan FJ, Osborne JP: Advances in the understanding of tuberous sclerosis. Arch Dis Child 2000;83:140-142.
6. Bruni O, Cortesi F, Giannotti F, Curatolo P: Sleep disorders in tuberous sclerosis: A polysomnographic study. Brain Dev 1995;17:52-56.
7. Palm L, Blennow G, Welterberg L: Long-term melatonin treatment in blind children and young adults with circadian sleep-wake disturbances. Dev Med Child Neurol 1997;39:319-325.
8. Weitzman ED, Czeisler CA, Colman RM, et al: Delayed sleep-phase syndrome, a chronobiological disorder with sleep-onset insomnia. Arch Gen Psychaitry 1981;38:737-746.
9. Sack RL, Lewy AJ, Blood ML, et al: Melatonin administration to blind people; phase advances and entrainment. J Biol Rhythms 1991;6:249-261.
10. Jan JE, Espezel H, Appleton RE: The treatment of sleep disorder with melatonin. Dev Med Child Neurol 1994;36:97-107.
11. McArthur AJ, Budden SS: Sleep dysfunction in Rett syndrome: A trial of exogenous melatonin treatment. Dev Med Child Neurol 1998;40:186-192.
12. O'Callaghan FJ, Clarke AA, Hancock E, et al: Use of melatonin to treat sleep disorders in the tuberous sclerosis complex. Dev Med Child Neurol 1999;41:123-126.
13. Camfield P, Gordon K, Dooley J, Camfield C: Melatonin appears ineffective in children with intellectual deficits and fragmented sleep: Six "n of 1" trials. J Child Neurol 1995;11: 341-343.
14. Sivan Y, Laudon M, Kuint J, Zisapel N: Low melatonin production in infants with a life-threatening event. Dev Med Child Neurol 2000;42:487-491.
15. Attanasio A, Borrelli P, Gupta D: Circadian rhythms in serum melatonin from infancy to adolescence. J Clin Endocrinol Metab 1985;61:388-390.